Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device

European Journal of Cardio-thoracic Surgery

Volumn 46, Issue 3, 2014, Pages 486-492

  Riebandt, Julia ^a   Haberl, Thomas ^a   Mahr, Stephane ^a   Laufer, Guenther ^a,b   Rajek, Angela ^a   Steinlechner, Barbara ^a   Schima, Heinrich ^a,b   Zimpfer, Daniel ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

Author keywords

Extracorporeal life support; INTERMACS Level; Ventricular assist device

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGATROBAN; ASPARTATE AMINOTRANSFERASE; CREATININE; DOBUTAMINE; HEPARIN; HYPERTENSIVE FACTOR; LEVOSIMENDAN; NORADRENALIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; APPLICATION SITE INFECTION; ARTERIAL THROMBOEMBOLISM; ARTICLE; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; BLOOD PUMP; CARDIOGENIC SHOCK; CAUSE OF DEATH; CLINICAL ARTICLE; CREATININE URINE LEVEL; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEART REINFARCTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; LIVER LEVEL; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PERICARDIAL DISEASE; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RESUSCITATION; RETROPERITONEAL HEMATOMA; RETROSPECTIVE STUDY; SUBCLAVIAN ARTERY; SURVIVAL RATE; SURVIVAL TIME; THROMBECTOMY; THROMBOSIS; TRICUSPID VALVE REPAIR; VENTRICULAR ASSIST DEVICE; CLINICAL TRIAL; EXTRACORPOREAL CIRCULATION; HEART ASSIST DEVICE; HEART SURGERY; KAPLAN MEIER METHOD; MIDDLE AGED; PREOPERATIVE CARE; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; EXTRACORPOREAL CIRCULATION; FEMALE; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84907361266     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu093     Document Type: Article

References (25)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.
2. Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 2012;31:601-10.
3. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013;32:141-56.
4. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012; 144:584-603; discussion 597-8.
5. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Int Med 2005;165:1643-50.
6. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001;122:92-102.
7. Stepanenko A, Potapov EV, Jurmann B, Lehmkuhl HB, Dandel M, Siniawski H et al. Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. J Heart Lung Transplant 2010;29:61-5.
8. Bermudez CA, Rocha RV, Toyoda Y, Zaldonis D, Sappington PL, Mulukutla S et al. Extracorporeal membrane oxygenation for advanced refractory shock in acute and chronic cardiomyopathy. Ann Thorac Surg 2011;92:2125-31.
9. Takayama H, Truby L, Koekort M, Uriel N, Colombo P, Mancini DM et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013;32:106-11.
10. Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010;139:302-11; 11 e1.
11. Smedira NG, Blackstone EH. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg 2001;71:S60-6; discussion S82-5.
12. Mihaljevic T, Jarrett CM, Gonzalez-Stawinski G, Smedira NG, Nowicki ER, Thuita L et al. Mechanical circulatory support after heart transplantation. Eur J Cardiothorac Surg 2012;41:200-6; discussion 06.
13. Pokersnik JA, Buda T, Bashour CA, Gonzalez-Stawinski GV. Have changes in ECMO technology impacted outcomes in adult patients developing postcardiotomy cardiogenic shock? J Card Surg 2012;27:246-52.
14. Anyanwu AC. Technique for less invasive implantation of Heartmate II left ventricular assist device without median sternotomy. Semin Thorac Cardiovasc Surg 2011;23:241-4.
15. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010;29:S1-39.
16. Noon GP, Morley DL, Irwin S, Abdelsayed SV, Benkowski RJ, Lynch BE. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 2001;71:S133-8; discussion S44-6.
17. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448-54.
18. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-8.
19. Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: a strategy to optimize survival and resource utilization. Circulation 1999;100:II206-10.
20. Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 2001;71: S77-81; discussion S82-5.
21. Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 2013;34:112-20.
22. Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010;121:214-20.
23. Hoefer D, Ruttmann E, Poelzl G, Kilo J, Hoermann C, Margreiter R et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg 2006;82:28-33.
24. Aigner C, Wisser W, Taghavi S, Lang G, Jaksch P, Czyzewski D et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg 2007;31:468-73; discussion 73-4.
25. Lebreton G, Nicolescu M, Leger P, Leprince P. Implantation of left ventricular support under extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2011;40:e165-7.